$SYBX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in SYNLOGIC, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in SYNLOGIC, INC.. Get notifications about new insider transactions in SYNLOGIC, INC. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 14 2021 | SYBX | SYNLOGIC, INC. | Barrett Peter | Director | Option Exercise | A | 3.67 | 12,818 | 47,042 | 12,818 | |
| Apr 22 2021 | SYBX | SYNLOGIC, INC. | ORBIMED ADVISORS LLC | Director | Grant | A | 3.00 | 1,666,666 | 4,999,998 | 3,696,662 | 2 M to 3.7 M (+82.10 %) |
| Apr 22 2021 | SYBX | SYNLOGIC, INC. | Khuong Chau Quang | Director | Grant | A | 3.00 | 1,666,666 | 4,999,998 | 3,696,662 | 2 M to 3.7 M (+82.10 %) |
| Mar 12 2021 | SYBX | SYNLOGIC, INC. | Riese Richard J. | Chief Medical Offic ... | Option Exercise | A | 3.50 | 70,000 | 245,000 | 70,000 | |
| Mar 12 2021 | SYBX | SYNLOGIC, INC. | Riese Richard J. | Chief Medical Offic ... | Grant | A | 0.00 | 17,500 | 0 | 39,000 | 21.5 K to 39 K (+81.40 %) |
| Mar 12 2021 | SYBX | SYNLOGIC, INC. | Riese Richard J. | Chief Medical Offic ... | Option Exercise | A | 3.50 | 70,000 | 245,000 | 70,000 | |
| Mar 12 2021 | SYBX | SYNLOGIC, INC. | Riese Richard J. | Chief Medical Offic ... | Grant | A | 0.00 | 17,500 | 0 | 39,000 | 21.5 K to 39 K (+81.40 %) |
| Mar 12 2021 | SYBX | SYNLOGIC, INC. | Brennan Aoife | See Remarks | Option Exercise | A | 3.50 | 285,000 | 997,500 | 285,000 | |
| Mar 12 2021 | SYBX | SYNLOGIC, INC. | Brennan Aoife | See Remarks | Option Exercise | A | 3.50 | 285,000 | 997,500 | 285,000 | |
| Mar 12 2021 | SYBX | SYNLOGIC, INC. | Brennan Aoife | See Remarks | Grant | A | 0.00 | 71,250 | 0 | 177,317 | 106.1 K to 177.3 K (+67.17 %) |
| Mar 12 2021 | SYBX | SYNLOGIC, INC. | Brennan Aoife | See Remarks | Grant | A | 0.00 | 71,250 | 0 | 177,317 | 106.1 K to 177.3 K (+67.17 %) |
| Mar 12 2021 | SYBX | SYNLOGIC, INC. | Awad Antoine | Chief Operating Off ... | Option Exercise | A | 3.50 | 70,000 | 245,000 | 70,000 | |
| Mar 12 2021 | SYBX | SYNLOGIC, INC. | Awad Antoine | Chief Operating Off ... | Grant | A | 0.00 | 17,500 | 0 | 43,000 | 25.5 K to 43 K (+68.63 %) |
| Mar 12 2021 | SYBX | SYNLOGIC, INC. | Awad Antoine | Chief Operating Off ... | Option Exercise | A | 3.50 | 70,000 | 245,000 | 70,000 | |
| Mar 12 2021 | SYBX | SYNLOGIC, INC. | Awad Antoine | Chief Operating Off ... | Grant | A | 0.00 | 17,500 | 0 | 43,000 | 25.5 K to 43 K (+68.63 %) |
| Dec 09 2020 | SYBX | SYNLOGIC, INC. | Heffernan Michael Thomas | Director | Option Exercise | A | 2.29 | 30,000 | 68,700 | 30,000 | |
| Jul 28 2020 | SYBX | SYNLOGIC, INC. | Barrett Peter | Director | Option Exercise | A | 2.23 | 1,541 | 3,436 | 1,541 | |
| Jul 28 2020 | SYBX | SYNLOGIC, INC. | Barrett Peter | Director | Option Exercise | A | 2.68 | 48,656 | 130,398 | 48,656 | |
| Jul 28 2020 | SYBX | SYNLOGIC, INC. | Barrett Peter | Director | Option Exercise | A | 2.23 | 1,541 | 3,436 | 1,541 | |
| Jul 28 2020 | SYBX | SYNLOGIC, INC. | Barrett Peter | Director | Option Exercise | A | 2.68 | 48,656 | 130,398 | 48,656 | |
| Jun 08 2020 | SYBX | SYNLOGIC, INC. | Hurter Patricia N. | Director | Option Exercise | A | 2.22 | 15,000 | 33,300 | 15,000 | |
| Jun 08 2020 | SYBX | SYNLOGIC, INC. | Mathers Edward T | Director | Option Exercise | A | 2.22 | 15,000 | 33,300 | 15,000 | |
| Jun 08 2020 | SYBX | SYNLOGIC, INC. | Khuong Chau Quang | Director | Option Exercise | A | 2.22 | 15,000 | 33,300 | 15,000 | |
| Jun 08 2020 | SYBX | SYNLOGIC, INC. | Shea Richard P | Director | Option Exercise | A | 2.22 | 15,000 | 33,300 | 15,000 | |
| Jun 08 2020 | SYBX | SYNLOGIC, INC. | Burgess Michael F. | Director | Option Exercise | A | 2.22 | 15,000 | 33,300 | 15,000 | |
| Jun 08 2020 | SYBX | SYNLOGIC, INC. | Leschly Nick | Director | Option Exercise | A | 2.22 | 15,000 | 33,300 | 15,000 | |
| Jun 08 2020 | SYBX | SYNLOGIC, INC. | Barrett Peter | Director | Option Exercise | A | 2.22 | 15,000 | 33,300 | 15,000 | |
| Mar 12 2020 | SYBX | SYNLOGIC, INC. | Riese Richard J. | Chief Medical Offic ... | Option Exercise | A | 1.70 | 54,000 | 91,800 | 54,000 | |
| Mar 12 2020 | SYBX | SYNLOGIC, INC. | Riese Richard J. | Chief Medical Offic ... | Grant | A | 0.00 | 13,500 | 0 | 21,500 | 8 K to 21.5 K (+168.75 %) |
| Mar 12 2020 | SYBX | SYNLOGIC, INC. | Brennan Aoife | See Remarks | Option Exercise | A | 1.70 | 185,300 | 315,010 | 185,300 | |
| Mar 12 2020 | SYBX | SYNLOGIC, INC. | Brennan Aoife | See Remarks | Grant | A | 0.00 | 46,300 | 0 | 106,067 | 59.8 K to 106.1 K (+77.47 %) |
| Feb 04 2020 | SYBX | SYNLOGIC, INC. | Burgess Michael F. | Director | Option Exercise | A | 2.51 | 30,000 | 75,300 | 30,000 | |
| Feb 04 2020 | SYBX | SYNLOGIC, INC. | Burgess Michael F. | Director | Option Exercise | A | 2.51 | 30,000 | 75,300 | 30,000 | |
| Jan 02 2020 | SYBX | SYNLOGIC, INC. | Riese Richard J. | Chief Medical Offic ... | Option Exercise | A | 2.58 | 150,000 | 387,000 | 150,000 | |
| Dec 16 2019 | SYBX | SYNLOGIC, INC. | Shea Richard P | Director | Buy | P | 2.74 | 7,500 | 20,550 | 7,500 | 0 to 7.5 K |
| Oct 24 2019 | SYBX | SYNLOGIC, INC. | BELOFF GREGG | See Remarks | Option Exercise | A | 2.30 | 50,000 | 115,000 | 50,000 | |
| Sep 25 2019 | SYBX | SYNLOGIC, INC. | PLEVY SCOTT ERIC | Chief Scientific Of ... | Grant | A | 0.00 | 8,000 | 0 | 8,000 | 0 to 8 K |
| Sep 25 2019 | SYBX | SYNLOGIC, INC. | Riese Richard J. | Chief Medical Offic ... | Grant | A | 0.00 | 8,000 | 0 | 8,000 | 0 to 8 K |
| Sep 25 2019 | SYBX | SYNLOGIC, INC. | Brennan Aoife | See Remarks | Grant | A | 0.00 | 8,000 | 0 | 59,767 | 51.8 K to 59.8 K (+15.45 %) |
| Jul 01 2019 | SYBX | SYNLOGIC, INC. | PLEVY SCOTT ERIC | Chief Scientific Of ... | Option Exercise | A | 9.10 | 150,000 | 1,365,000 | 150,000 | |
| Jun 07 2019 | SYBX | SYNLOGIC, INC. | Mathers Edward T | Director | Option Exercise | A | 7.30 | 10,000 | 73,000 | 10,000 | |
| Jun 07 2019 | SYBX | SYNLOGIC, INC. | Leschly Nick | Director | Option Exercise | A | 7.30 | 10,000 | 73,000 | 10,000 | |
| Jun 07 2019 | SYBX | SYNLOGIC, INC. | Hurter Patricia N. | Director | Option Exercise | A | 7.30 | 10,000 | 73,000 | 10,000 | |
| Jun 07 2019 | SYBX | SYNLOGIC, INC. | Barrett Peter | Director | Option Exercise | A | 7.30 | 10,000 | 73,000 | 10,000 | |
| Jun 07 2019 | SYBX | SYNLOGIC, INC. | POWELL MICHAEL | Director | Option Exercise | A | 7.30 | 10,000 | 73,000 | 10,000 | |
| Jun 07 2019 | SYBX | SYNLOGIC, INC. | Shea Richard P | Director | Option Exercise | A | 7.30 | 10,000 | 73,000 | 10,000 | |
| Apr 09 2019 | SYBX | SYNLOGIC, INC. | Barrett Peter | Director | Option Exercise | A | 7.62 | 17,380 | 132,436 | 17,380 | |
| Mar 06 2019 | SYBX | SYNLOGIC, INC. | Brennan Aoife | See Remarks | Option Exercise | A | 8.59 | 185,000 | 1,589,150 | 185,000 | |
| Mar 06 2019 | SYBX | SYNLOGIC, INC. | Shegog Todd | See Remarks | Option Exercise | A | 8.59 | 58,500 | 502,515 | 58,500 | |
| Feb 14 2019 | SYBX | SYNLOGIC, INC. | Miller Paul Francis | Chief Scientific Of ... | Sell | S | 9.75 | 5,849 | 57,028 | 48,135 | 54 K to 48.1 K (-10.83 %) |
| Feb 14 2019 | SYBX | SYNLOGIC, INC. | Miller Paul Francis | Chief Scientific Of ... | Sell | S | 9.75 | 3,151 | 30,722 | 53,984 | 57.1 K to 54 K (-5.52 %) |
| Feb 12 2019 | SYBX | SYNLOGIC, INC. | Hurter Patricia N. | Director | Option Exercise | A | 8.91 | 20,000 | 178,200 | 20,000 | |
| Nov 01 2018 | SYBX | SYNLOGIC, INC. | Brennan Aoife | President and CEO | Option Exercise | A | 7.91 | 150,000 | 1,186,500 | 150,000 | |
| Oct 19 2018 | SYBX | SYNLOGIC, INC. | Miller Paul Francis | Chief Scientific Of ... | Sell | S | 9.77 | 3,000 | 29,296 | 57,135 | 60.1 K to 57.1 K (-4.99 %) |
| Sep 19 2018 | SYBX | SYNLOGIC, INC. | Miller Paul Francis | Chief Scientific Of ... | Sell | S | 13.05 | 3,000 | 39,163 | 60,135 | 63.1 K to 60.1 K (-4.75 %) |
| Sep 07 2018 | SYBX | SYNLOGIC, INC. | Miller Paul Francis | Chief Scientific Of ... | Sell | S | 12.55 | 3,000 | 37,635 | 63,135 | 66.1 K to 63.1 K (-4.54 %) |
| Aug 31 2018 | SYBX | SYNLOGIC, INC. | Miller Paul Francis | Chief Scientific Of ... | Sell | S | 9.76 | 1,342 | 13,092 | 66,135 | 67.5 K to 66.1 K (-1.99 %) |
| Aug 31 2018 | SYBX | SYNLOGIC, INC. | Miller Paul Francis | Chief Scientific Of ... | Sell | S | 9.77 | 1,658 | 16,198 | 67,477 | 69.1 K to 67.5 K (-2.40 %) |
| Jul 19 2018 | SYBX | SYNLOGIC, INC. | Miller Paul Francis | Chief Scientific Of ... | Sell | S | 11.01 | 3,000 | 33,022 | 69,135 | 72.1 K to 69.1 K (-4.16 %) |
| Jun 21 2018 | SYBX | SYNLOGIC, INC. | Miller Paul Francis | Chief Scientific Of ... | Sell | S | 9.75 | 1,000 | 9,750 | 72,135 | 73.1 K to 72.1 K (-1.37 %) |
| Jun 21 2018 | SYBX | SYNLOGIC, INC. | Miller Paul Francis | Chief Scientific Of ... | Sell | S | 9.80 | 1,054 | 10,329 | 72,135 | 73.2 K to 72.1 K (-1.44 %) |
| Jun 21 2018 | SYBX | SYNLOGIC, INC. | Miller Paul Francis | Chief Scientific Of ... | Sell | S | 9.75 | 946 | 9,224 | 74,189 | 75.1 K to 74.2 K (-1.26 %) |
| Jun 14 2018 | SYBX | SYNLOGIC, INC. | Mathers Edward T | Director | Option Exercise | A | 9.36 | 10,000 | 93,600 | 10,000 | |
| Jun 14 2018 | SYBX | SYNLOGIC, INC. | Leschly Nick | Director | Option Exercise | A | 9.36 | 10,000 | 93,600 | 10,000 | |
| Jun 14 2018 | SYBX | SYNLOGIC, INC. | Barrett Peter | Director | Option Exercise | A | 9.36 | 10,000 | 93,600 | 10,000 | |
| Jun 14 2018 | SYBX | SYNLOGIC, INC. | POWELL MICHAEL | Director | Option Exercise | A | 9.36 | 10,000 | 93,600 | 10,000 | |
| Jun 14 2018 | SYBX | SYNLOGIC, INC. | Khuong Chau Quang | Director | Option Exercise | A | 9.36 | 10,000 | 93,600 | 10,000 | |
| Jun 14 2018 | SYBX | SYNLOGIC, INC. | Shea Richard P | Director | Option Exercise | A | 9.36 | 10,000 | 93,600 | 10,000 | |
| Jun 06 2018 | SYBX | SYNLOGIC, INC. | Brennan Aoife | Interim President a ... | Option Exercise | A | 9.55 | 54,000 | 515,700 | 54,000 | |
| Mar 16 2018 | MIRN | SYNLOGIC, INC. | Gutierrez-Ramos Jose-Carlos | See Remarks | Option Exercise | A | 9.95 | 120,540 | 1,199,373 | 120,540 | |
| Mar 15 2018 | MIRN | SYNLOGIC, INC. | Shegog Todd | See Remarks | Option Exercise | A | 9.95 | 48,000 | 477,600 | 48,000 | |
| Mar 15 2018 | MIRN | SYNLOGIC, INC. | Brennan Aoife | Chief Medical Offic ... | Option Exercise | A | 9.95 | 56,000 | 557,200 | 56,000 | |
| Mar 15 2018 | MIRN | SYNLOGIC, INC. | Gengos Andrew | Chief Operating Off ... | Option Exercise | A | 9.95 | 10,000 | 99,500 | 10,000 | |
| Mar 15 2018 | MIRN | SYNLOGIC, INC. | Miller Paul Francis | Chief Scientific Of ... | Option Exercise | A | 9.95 | 16,000 | 159,200 | 16,000 | |
| Jan 30 2018 | MIRN | SYNLOGIC, INC. | POWELL MICHAEL | Director | Grant | A | 9.75 | 150,000 | 1,462,500 | 574,972 | 425 K to 575 K (+35.30 %) |
| Jan 30 2018 | MIRN | SYNLOGIC, INC. | Khuong Chau Quang | Director | Grant | A | 9.75 | 715,000 | 6,971,250 | 2,029,996 | 1.3 M to 2 M (+54.37 %) |
| Jan 30 2018 | MIRN | SYNLOGIC, INC. | ORBIMED ADVISORS LLC | Director | Grant | A | 9.75 | 715,000 | 6,971,250 | 2,029,996 | 1.3 M to 2 M (+54.37 %) |
| Jan 26 2018 | MIRN | SYNLOGIC, INC. | Viswanathan Ravi | 10% Owner | Grant | A | 9.75 | 410,000 | 3,997,500 | 4,228,940 | 3.8 M to 4.2 M (+10.74 %) |
| Jan 26 2018 | MIRN | SYNLOGIC, INC. | Sonsini Peter W. | 10% Owner | Grant | A | 9.75 | 410,000 | 3,997,500 | 4,228,940 | 3.8 M to 4.2 M (+10.74 %) |
| Jan 26 2018 | MIRN | SYNLOGIC, INC. | SANDELL SCOTT D | 10% Owner | Grant | A | 9.75 | 410,000 | 3,997,500 | 4,228,940 | 3.8 M to 4.2 M (+10.74 %) |
| Jan 26 2018 | MIRN | SYNLOGIC, INC. | MOTT DAVID M | 10% Owner | Grant | A | 9.75 | 410,000 | 3,997,500 | 4,228,940 | 3.8 M to 4.2 M (+10.74 %) |
| Jan 26 2018 | MIRN | SYNLOGIC, INC. | KERINS PATRICK J | 10% Owner | Grant | A | 9.75 | 410,000 | 3,997,500 | 4,228,940 | 3.8 M to 4.2 M (+10.74 %) |
| Jan 26 2018 | MIRN | SYNLOGIC, INC. | Florence Anthony A. Jr. | 10% Owner | Grant | A | 9.75 | 410,000 | 3,997,500 | 4,228,940 | 3.8 M to 4.2 M (+10.74 %) |
| Jan 26 2018 | MIRN | SYNLOGIC, INC. | BARRIS PETER J | 10% Owner | Grant | A | 9.75 | 410,000 | 3,997,500 | 4,228,940 | 3.8 M to 4.2 M (+10.74 %) |
| Jan 26 2018 | MIRN | SYNLOGIC, INC. | BARRETT M JAMES | 10% Owner | Grant | A | 9.75 | 410,000 | 3,997,500 | 4,228,940 | 3.8 M to 4.2 M (+10.74 %) |
| Jan 26 2018 | MIRN | SYNLOGIC, INC. | New Enterprise Associates 14, ... | 10% Owner | Grant | A | 9.75 | 410,000 | 3,997,500 | 4,228,940 | 3.8 M to 4.2 M (+10.74 %) |
| Jan 03 2018 | MIRN | SYNLOGIC, INC. | Khuong Chau Quang | Director | Option Exercise | A | 9.70 | 17,143 | 166,287 | 17,143 | |
| Jan 03 2018 | MIRN | SYNLOGIC, INC. | Barrett Peter | Director | Option Exercise | A | 10.80 | 11,570 | 124,956 | 11,570 | |
| Jan 03 2018 | MIRN | SYNLOGIC, INC. | Barrett Peter | Director | Option Exercise | A | 9.70 | 17,143 | 166,287 | 17,143 | |
| Jan 03 2018 | MIRN | SYNLOGIC, INC. | Shea Richard P | Director | Option Exercise | A | 9.70 | 17,143 | 166,287 | 17,143 | |
| Jan 03 2018 | MIRN | SYNLOGIC, INC. | Leschly Nick | Director | Option Exercise | A | 9.70 | 17,143 | 166,287 | 17,143 | |
| Dec 22 2017 | MIRN | SYNLOGIC, INC. | Gengos Andrew | See Remarks | Option Exercise | A | 14.71 | 154,000 | 2,265,340 | 154,000 | |
| Aug 30 2017 | MIRN | SYNLOGIC, INC. | Viswanathan Ravi | 10% Owner | Grant | A | 0.00 | 3,394,439 | 0 | 3,818,940 | 424.5 K to 3.8 M (+799.63 %) |
| Aug 30 2017 | MIRN | SYNLOGIC, INC. | Sonsini Peter W. | 10% Owner | Grant | A | 0.00 | 3,394,439 | 0 | 3,818,940 | 424.5 K to 3.8 M (+799.63 %) |
| Aug 30 2017 | MIRN | SYNLOGIC, INC. | SANDELL SCOTT D | 10% Owner | Grant | A | 0.00 | 3,394,439 | 0 | 3,818,940 | 424.5 K to 3.8 M (+799.63 %) |
| Aug 30 2017 | MIRN | SYNLOGIC, INC. | MOTT DAVID M | 10% Owner | Grant | A | 0.00 | 3,394,439 | 0 | 3,818,940 | 424.5 K to 3.8 M (+799.63 %) |
| Aug 30 2017 | MIRN | SYNLOGIC, INC. | KERINS PATRICK J | 10% Owner | Grant | A | 0.00 | 3,394,439 | 0 | 3,818,940 | 424.5 K to 3.8 M (+799.63 %) |
| Aug 30 2017 | MIRN | SYNLOGIC, INC. | Florence Anthony A. Jr. | 10% Owner | Grant | A | 0.00 | 3,394,439 | 0 | 3,818,940 | 424.5 K to 3.8 M (+799.63 %) |
| Aug 30 2017 | MIRN | SYNLOGIC, INC. | BASKETT FOREST | 10% Owner | Grant | A | 0.00 | 3,394,439 | 0 | 3,818,940 | 424.5 K to 3.8 M (+799.63 %) |
| Aug 30 2017 | MIRN | SYNLOGIC, INC. | BARRIS PETER J | 10% Owner | Grant | A | 0.00 | 3,394,439 | 0 | 3,818,940 | 424.5 K to 3.8 M (+799.63 %) |
| Aug 30 2017 | MIRN | SYNLOGIC, INC. | BARRETT M JAMES | 10% Owner | Grant | A | 0.00 | 3,394,439 | 0 | 3,818,940 | 424.5 K to 3.8 M (+799.63 %) |
| Aug 30 2017 | MIRN | SYNLOGIC, INC. | Mathers Edward T | Director | Option Exercise | A | 12.07 | 1,428 | 17,236 | 1,428 | |
| Aug 30 2017 | MIRN | SYNLOGIC, INC. | New Enterprise Associates 14, ... | 10% Owner | Grant | A | 0.00 | 3,394,439 | 0 | 3,818,940 | 424.5 K to 3.8 M (+799.63 %) |
| Aug 30 2017 | MIRN | SYNLOGIC, INC. | Leschly Nick | Director | Option Exercise | A | 12.07 | 2,857 | 34,484 | 2,857 | |
| Aug 30 2017 | MIRN | SYNLOGIC, INC. | Shea Richard P | Director | Option Exercise | A | 12.07 | 2,857 | 34,484 | 2,857 | |
| Aug 30 2017 | MIRN | SYNLOGIC, INC. | Khuong Chau Quang | Director | Option Exercise | A | 12.07 | 2,857 | 34,484 | 2,857 | |
| Aug 30 2017 | MIRN | SYNLOGIC, INC. | Barrett Peter | Director | Option Exercise | A | 12.07 | 2,857 | 34,484 | 2,857 | |
| Aug 30 2017 | MIRN | SYNLOGIC, INC. | POWELL MICHAEL | Director | Option Exercise | A | 12.07 | 1,428 | 17,236 | 1,428 | |
| Dec 02 2016 | MIRN | Mirna Therapeutics ... | Irvin Jon | Vice President, Fin ... | Buy | S | 1.43 | 280 | 402 | 7,625 | 7.3 K to 7.6 K (+3.81 %) |
| Nov 15 2016 | MIRN | Mirna Therapeutics ... | Irvin Jon | Vice President, Fin ... | Sell | S | 1.45 | 150 | 218 | 7,905 | 8.1 K to 7.9 K (-1.86 %) |
| Nov 02 2016 | MIRN | Mirna Therapeutics ... | Irvin Jon | Vice President, Fin ... | Sell | S | 1.28 | 280 | 359 | 8,055 | 8.3 K to 8.1 K (-3.36 %) |
| Oct 12 2016 | MIRN | Mirna Therapeutics ... | Irvin Jon | Vice President, Fin ... | Sell | S | 1.83 | 150 | 274 | 8,335 | 8.5 K to 8.3 K (-1.77 %) |
| Oct 05 2016 | MIRN | Mirna Therapeutics ... | Irvin Jon | Vice President, Fin ... | Sell | S | 1.93 | 250 | 481 | 8,485 | 8.7 K to 8.5 K (-2.86 %) |
| Sep 06 2016 | MIRN | Mirna Therapeutics ... | SIEGALL CLAY B | Director | Option Exercise | A | 4.74 | 10,000 | 47,400 | 10,000 | |
| Sep 06 2016 | MIRN | Mirna Therapeutics ... | Mathers Edward T | Director | Option Exercise | A | 4.74 | 10,000 | 47,400 | 10,000 | |
| Sep 06 2016 | MIRN | Mirna Therapeutics ... | POWELL MICHAEL | Director | Option Exercise | A | 4.74 | 10,000 | 47,400 | 10,000 | |
| Sep 06 2016 | MIRN | Mirna Therapeutics ... | Alleva Lawrence M | Director | Option Exercise | A | 4.74 | 10,000 | 47,400 | 10,000 | |
| Sep 06 2016 | MIRN | Mirna Therapeutics ... | Greenleaf Peter | Director | Option Exercise | A | 4.74 | 10,000 | 47,400 | 10,000 | |
| Sep 06 2016 | MIRN | Mirna Therapeutics ... | Winkler Matthew | Director | Option Exercise | A | 4.74 | 10,000 | 47,400 | 10,000 | |
| Sep 06 2016 | MIRN | Mirna Therapeutics ... | Nisen Perry | Director | Option Exercise | A | 4.74 | 20,000 | 94,800 | 20,000 | |
| Mar 14 2016 | MIRN | Mirna Therapeutics ... | Greenleaf Peter | Director | Option Exercise | A | 4.36 | 8,000 | 34,880 | 8,000 | |
| Mar 14 2016 | MIRN | Mirna Therapeutics ... | Irvin Jon | Vice President, Fin ... | Option Exercise | A | 4.36 | 10,000 | 43,600 | 10,000 | |
| Mar 14 2016 | MIRN | Mirna Therapeutics ... | DeYoung Casi | Chief Business Offi ... | Option Exercise | A | 4.36 | 60,000 | 261,600 | 60,000 | |
| Mar 14 2016 | MIRN | Mirna Therapeutics ... | Fuhrman Alan | Chief Financial Off ... | Option Exercise | A | 4.36 | 60,000 | 261,600 | 60,000 | |
| Mar 14 2016 | MIRN | Mirna Therapeutics ... | Lammers Paul | President & CEO | Option Exercise | A | 4.36 | 165,000 | 719,400 | 165,000 | |
| Mar 02 2016 | MIRN | Mirna Therapeutics ... | Greenleaf Peter | Director | Option Exercise | A | 4.55 | 12,000 | 54,600 | 12,000 | |
| Apr 26 2016 | MIRN | Mirna Therapeutics ... | O'Neill Vincent | Chief Medical Offic ... | Option Exercise | A | 4.42 | 250,000 | 1,105,000 | 250,000 | |
| Oct 07 2015 | MIRN | Mirna Therapeutics ... | PFIZER INC | 10% Owner | Option Exercise | C | 0.00 | 491,418 | 0 | 0 | |
| Oct 07 2015 | MIRN | Mirna Therapeutics ... | PFIZER INC | 10% Owner | Option Exercise | C | 0.00 | 1,047,806 | 0 | 0 | |
| Oct 07 2015 | MIRN | Mirna Therapeutics ... | PFIZER INC | 10% Owner | Buy | J | 7.00 | 235,855 | 1,650,985 | 2,489,364 | 2.3 M to 2.5 M (+10.47 %) |
| Oct 07 2015 | MIRN | Mirna Therapeutics ... | PFIZER INC | 10% Owner | Buy | P | 7.00 | 714,285 | 4,999,995 | 2,253,509 | 1.5 M to 2.3 M (+46.41 %) |
| Oct 07 2015 | MIRN | Mirna Therapeutics ... | PFIZER INC | 10% Owner | Buy | C | 0.00 | 1,539,224 | 0 | 1,539,224 | 0 to 1.5 M |
| Oct 06 2015 | MIRN | Mirna Therapeutics ... | Sofinnova Venture Partners VII ... | 10% Owner | Option Exercise | C | 0.00 | 583,559 | 0 | 0 | |
| Oct 06 2015 | MIRN | Mirna Therapeutics ... | Sofinnova Venture Partners VII ... | 10% Owner | Option Exercise | C | 0.00 | 1,244,269 | 0 | 0 | |
| Oct 06 2015 | MIRN | Mirna Therapeutics ... | Sofinnova Venture Partners VII ... | 10% Owner | Buy | P | 7.00 | 857,142 | 5,999,994 | 2,974,811 | 2.1 M to 3 M (+40.48 %) |
| Oct 06 2015 | MIRN | Mirna Therapeutics ... | Sofinnova Venture Partners VII ... | 10% Owner | Buy | J | 0.00 | 289,841 | 0 | 2,117,669 | 1.8 M to 2.1 M (+15.86 %) |
| Oct 06 2015 | MIRN | Mirna Therapeutics ... | Sofinnova Venture Partners VII ... | 10% Owner | Buy | C | 0.00 | 583,559 | 0 | 1,827,828 | 1.2 M to 1.8 M (+46.90 %) |
| Oct 06 2015 | MIRN | Mirna Therapeutics ... | Sofinnova Venture Partners VII ... | 10% Owner | Buy | C | 0.00 | 1,244,269 | 0 | 1,244,269 | 0 to 1.2 M |
| Oct 06 2015 | MIRN | Mirna Therapeutics ... | Weller Harry R | 10% Owner | Option Exercise | C | 0.00 | 583,559 | 0 | 0 | |
| Oct 06 2015 | MIRN | Mirna Therapeutics ... | Weller Harry R | 10% Owner | Option Exercise | C | 0.00 | 1,241,650 | 0 | 0 | |
| Oct 06 2015 | MIRN | Mirna Therapeutics ... | Weller Harry R | 10% Owner | Buy | P | 7.00 | 857,142 | 5,999,994 | 2,971,517 | 2.1 M to 3 M (+40.54 %) |
| Oct 06 2015 | MIRN | Mirna Therapeutics ... | Weller Harry R | 10% Owner | Buy | J | 0.00 | 31,650 | 0 | 2,114,375 | 2.1 M to 2.1 M (+1.52 %) |
| Oct 06 2015 | MIRN | Mirna Therapeutics ... | Weller Harry R | 10% Owner | Buy | C | 0.00 | 583,559 | 0 | 2,082,725 | 1.5 M to 2.1 M (+38.93 %) |
| Oct 06 2015 | MIRN | Mirna Therapeutics ... | Weller Harry R | 10% Owner | Buy | J | 0.00 | 257,516 | 0 | 1,499,166 | 1.2 M to 1.5 M (+20.74 %) |
| Oct 06 2015 | MIRN | Mirna Therapeutics ... | Weller Harry R | 10% Owner | Buy | C | 0.00 | 1,241,650 | 0 | 1,241,650 | 0 to 1.2 M |
| Oct 06 2015 | MIRN | Mirna Therapeutics ... | Viswanathan Ravi | 10% Owner | Option Exercise | C | 0.00 | 583,559 | 0 | 0 | |
| Oct 06 2015 | MIRN | Mirna Therapeutics ... | Viswanathan Ravi | 10% Owner | Option Exercise | C | 0.00 | 1,241,650 | 0 | 0 | |
| Oct 06 2015 | MIRN | Mirna Therapeutics ... | Viswanathan Ravi | 10% Owner | Buy | P | 7.00 | 857,142 | 5,999,994 | 2,971,517 | 2.1 M to 3 M (+40.54 %) |
| Oct 06 2015 | MIRN | Mirna Therapeutics ... | Viswanathan Ravi | 10% Owner | Buy | J | 0.00 | 31,650 | 0 | 2,114,375 | 2.1 M to 2.1 M (+1.52 %) |
| Oct 06 2015 | MIRN | Mirna Therapeutics ... | Viswanathan Ravi | 10% Owner | Buy | C | 0.00 | 583,559 | 0 | 2,082,725 | 1.5 M to 2.1 M (+38.93 %) |